Helene D Gayle
CIK 1487047 · last filed 2026-06-15
Helene D Gayle is a corporate insider who has filed 67 SEC Form 4 insider transactions across 5 companies since 2010. The most recent filing, for OGN, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.5M across reported positions. 21 SEC filings were submitted jointly with COCA COLA CO.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
30 HUDSON STREET
JERSEY CITY, NJ 07302
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGN | Director | — | $13.75 | — | $0 | 6 | 2026-06-15 |
| PANW | Director | 26,100 | $354.92 | $9.26M | $0 | 5 | 2024-12-17 |
| KO | Director | 3,000 | $95.34 | $286.0K | $81.1K | 19 | 2024-04-03 |
| GoHealth, Inc. (GOCO) Delisted | Director | 476 | $0.30 | $145 | $0 | 3 | 2021-09-16 |
| CL | Director | 40,752 | $97.39 | $3.97M | -$3.16M | 34 | 2021-04-05 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | OGN | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | OGN | Grant (A) | — | $0 | EDGAR |
| 2024-12-17 | PANW | — | — | $0 | EDGAR |
| 2024-12-11 | PANW | Grant (A) | +915 | $0 | EDGAR |
| 2024-06-11 | OGN | Grant (A) | — | $0 | EDGAR |
| 2024-04-03 | KO | Grant (A) | — | $0 | EDGAR |
| 2023-12-13 | PANW | Grant (A) | +1,308 | $0 | EDGAR |
| 2023-06-13 | OGN | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | KO | Grant (A) | — | $0 | EDGAR |
| 2022-12-14 | PANW | Grant (A) | +2,157 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.